N/A
N=1,175
Toronto Thromboprophylaxis Patient Safety Initiative
Venous Thromboembolism
Bottom Line
View on ClinicalTrials.gov: NCT01869075 ↗Enrolled (actual)
1,175
Serious AEs
0.0%
Results posted
Sep 2014
Primary outcome: Primary: Percentage of Patients Prescribed Appropriate VTE Prophylaxis — 64; 62; 67; 54 percentage of patients
Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- Knowledge Translation (KT) toolkit (Other)
- Age
- Adult, Older Adult · 18+ yrs
- Sex
- All
- Sponsor
- Sunnybrook Health Sciences Centre
- Primary completion
- Mar 2009
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Percentage of Patients Prescribed Appropriate VTE Prophylaxis |
64; 62; 67; 54; 85; 76 | — |
Summary
Venous thromboembolism (VTE), which includes deep vein thrombosis (DVT) and pulmonary embolism (PE, is one of the common and preventable complications of hospital stay. VTE prophylaxis through the use of evidence-based anticoagulant medication options or mechanical prophylaxis have been shown to reduce this risk and improve patient safety. Despite an abundance of evidence, use of VTE prophylaxis remains low.
This study assesses the effectiveness of quality improvement strategies (use of pre-printed orders, audit and feedback, involvement of the pharmacist as project need and as a reminder to the physician, and education of staff) on use of appropriate VTE prophylaxis. The study aims to measure if the use of these strategies improves the use of VTE prophylaxis and therefore, improves patient safety and patient care by reducing the risk of developing DVT or PE.
Eligibility Criteria
Inclusion Criteria
- age at least 18 years
- at risk for VTE
Exclusion Criteria
- on therapeutic anticoagulation
Data sourced from ClinicalTrials.gov (NCT01869075). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.